Cost-effectiveness analysis of alternative anticoagulation in suspected heparin-induced thrombocytopenia

Heparin-induced thrombocytopenia (HIT) is a life-threatening complication associated with high medical costs. Factor Xa inhibitors gradually replace approved treatment with intravenous direct thrombin inhibitors despite their off-label indication, because of easier management and favorable economic...

Descripción completa

Detalles Bibliográficos
Autores principales: Tuleja, Aleksandra, Salvador, Dante, Muka, Taulant, Bernhard, Sarah, Lenz, Armando, Baumgartner, Iris, Schindewolf, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Thrombosis and Hemostasis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131923/
https://www.ncbi.nlm.nih.gov/pubmed/35147675
http://dx.doi.org/10.1182/bloodadvances.2022007017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131923/
https://www.ncbi.nlm.nih.gov/pubmed/35147675
http://dx.doi.org/10.1182/bloodadvances.2022007017

Ejemplares similares